The State of Clinical AI in Indian Healthcare 2026

1. The Current Landscape

India's healthcare system serves over 1.4 billion people through a complex network of public hospitals, private multispecialty chains, standalone specialist clinics, diagnostic laboratories, and rural primary health centres. The system processes an estimated 3.5 billion outpatient visits annually, creating both an enormous data generation opportunity and a significant operational challenge.

A System in Transition

The Elsevier "Clinician of the Future 2025" report, based on a survey of 2,200 clinicians across 109 countries including 275 from India, revealed that 40% of Indian clinicians now actively use AI technologies for clinical or administrative purposes. This represents a three-fold increase from 12% in 2024, placing India ahead of the United States (36%) and the United Kingdom (34%), though behind China (71%) and the broader Asia Pacific region (56%).1

India leads global AI adoption at 92% across all sectors according to Visual Capitalist's 2026 analysis, the highest rate among surveyed countries.5 Several factors drive this: a young, tech-savvy workforce; intense competitive pressure among healthcare providers; a regulatory environment that has historically favoured innovation; and the sheer scale of unmet healthcare demand that makes automation economically compelling.

The Digital Divide

However, this headline figure obscures a critical structural divide. India's healthcare delivery is dominated numerically by small practices: solo practitioners, two-to-five doctor clinics, and neighbourhood diagnostic centres. These facilities, numbering in the hundreds of thousands, operate with fundamentally different technology constraints than the Apollo Hospitals and Fortis chains of the world.

While large hospital chains have invested heavily in enterprise EMR systems, PACS infrastructure, and AI-powered clinical decision support, the vast majority of smaller clinics continue to rely on paper-based records or, at best, basic billing software with no clinical data capture. The adoption of electronic medical records in India's small clinic segment remains significantly below developed-market benchmarks, where the United States achieved 96% hospital EHR adoption through years of government incentives.6

Funding and Investment

The investment landscape tells a story of growing confidence. Qure.ai, India's most prominent healthcare AI company focused on medical imaging, raised USD 65 million in Series D funding in September 2024, bringing total funding to USD 141.3 million. The company was named to TIME Magazine's list of most influential companies in 2025 and has announced plans for an IPO within two years.7 Practo, India's largest digital health platform with over 40 crore (400 million) consumers and 150,000 doctors, reported revenues of INR 240 crore in FY2024 with 22% year-over-year growth and achieved profitability.8

2. Government Digital Health Infrastructure

India's government has made digital health infrastructure a national priority, deploying one of the most ambitious digital public goods programs in global healthcare. The architecture mirrors India's successful Unified Payments Interface (UPI) model: government builds the rails, private players build the applications.

Ayushman Bharat Digital Mission (ABDM)

Launched in September 2021, ABDM has achieved extraordinary scale by mid-2026:

The ABDM ecosystem comprises several interlocking components:3

• ABHA (Ayushman Bharat Health Account): A 14-digit unique health identifier that links all health records across hospitals, labs, insurers, and national health programs with patient consent.
• Healthcare Professionals Registry (HPR): A national registry of all healthcare professionals, from allopathic doctors to AYUSH practitioners, verified and digitally connected.
• Health Facility Registry (HFR): A national registry of health facilities including hospitals, clinics, labs, and pharmacies, both public and private.
• Unified Health Interface (UHI): An open network for health services, built on principles similar to UPI for payments, enabling any patient to discover and connect with any verified provider regardless of the application used.
• National Health Claims Exchange (NHCX): A digital highway for exchanging claims-related information among payers, providers, and beneficiaries.

Aarogya Setu 2.0

Launched on June 29, 2026, the revamped Aarogya Setu platform now serves as India's citizen-facing digital health gateway, integrating ABHA profiles, digital health records, PM-JAY insurance services, and emergency healthcare into a single application. Originally built as a COVID-19 contact tracing tool, its transformation into a comprehensive Personal Health Record platform represents a deliberate strategy to accelerate digital health adoption by leveraging an app already installed on hundreds of millions of devices.3

eSushrut@Clinic

Recognizing the challenge of digitizing India's vast small-clinic segment, the government launched eSushrut@Clinic in June 2026. Developed by the Centre for Development of Advanced Computing (C-DAC), this lightweight Hospital Management Information System enables small clinics to digitize patient records and streamline administrative functions affordably. Over 2,200 healthcare facilities have been onboarded since launch.3

Digital Health Incentive Scheme (DHIS)

To accelerate participation, the government provides direct financial incentives. As of June 2026, the scheme has disbursed INR 107+ crore to hospitals, INR 2.95 crore to diagnostics labs and pharmacies, and INR 26+ crore to digital solution companies for creating interoperable digital health records linked to ABDM.3

IndiaAI Mission

Approved in March 2024 with a budget outlay of INR 10,371.92 crore (approximately USD 1.24 billion), the IndiaAI Mission focuses on building sovereign AI infrastructure.4 Key achievements include:

• Over 38,000 GPUs deployed through a subsidized national compute facility via public-private partnerships
• AIKosh: a national repository hosting over 9,500 datasets and 273 sectoral models
• National Supercomputing Mission: 40+ petaflop systems operationalized, including AIRAWAT and PARAM Siddhi-AI
• Capacity building: supporting 500 PhDs, 5,000 postgraduates, 8,000 undergraduates in AI
• 570 AI Data Labs and 27 IndiaAI labs established across states

3. AI Applications in Clinical Practice

Clinical AI in India has matured beyond proof-of-concept demonstrations into production deployments across multiple domains. The most significant traction is in diagnostic imaging, followed by clinical decision support, administrative automation, and remote patient monitoring.

Diagnostic Imaging and Radiology

Radiology represents the domain where AI has achieved the deepest measured clinical impact in India. By 2026, AI sits inside live diagnostic workflows at hundreds of hospitals across Tier 1, Tier 2, and Tier 3 cities.9

The market has consolidated around two architectural models:

5C Network, operating one of India's largest deployed radiology AI platforms, processes over 15,000 scans daily for 2,000+ hospitals. Their platform combines computer vision (Bionic Vision), voice-to-report (Bionic Voice), and quality control AI (Bionic LM) in a single workflow with 400+ board-certified radiologists.9

Four use-cases drive production value:

1. Triage and prioritization: AI identifies highest-acuity studies (intracranial bleeds, large-vessel occlusion, pneumothorax) and pushes them to the front of the radiologist queue.
2. Pre-read pathology detection: AI marks suspected findings on images before radiologist review, including TB lesions, lung nodules, and fractures.
3. Quantification: Automated measurement of lung nodules, Cobb angle calculations, volumetric analysis on stroke CTs.
4. Concurrent quality control: AI checks reports for contradictions, missing sections, and unanswered clinical questions before sign-off, reducing rejection rates by approximately 40%.

Cardiac Care

Tricog Health has deployed AI-powered cardiac diagnostics enabling faster and more accessible heart care through instant ECG interpretation and remote cardiology consultation. The system connects primary care facilities with cardiologists, reducing time-to-treatment for acute cardiac events in locations where specialist access would otherwise require hours of travel.

Clinical Decision Support and EMR

HealthPlix has built India's most widely deployed AI-powered EMR for outpatient doctors, with the platform serving over 10,000 physicians. Their HALO system automates clinical documentation, allowing doctors to focus on patients rather than data entry. The platform provides real-time clinical decision support, suggesting diagnostic pathways and treatment protocols based on presented symptoms and patient history.10

Pathology and Blood Analysis

SigTuple uses AI and robotics to analyze blood smears, urine samples, and other pathology specimens. Their cloud-based platform performs automated microscopy with machine learning analysis, addressing the critical shortage of trained pathologists in India, particularly in Tier 2 and Tier 3 cities.

Cancer Screening

Niramai (Non-Invasive Risk Assessment with Machine Intelligence) developed a thermal imaging-based AI system for early breast cancer detection. The portable, non-contact system is particularly significant for India, where mammography infrastructure is limited and cultural barriers to traditional screening persist in many communities.

Administrative Automation

Approximately 60% of healthcare AI investments in 2024 and 2025 focused on administrative automation, reflecting the sector's immediate priority to reduce operational costs.11 Applications include automated appointment scheduling, insurance claims processing, billing optimization, and patient communication management.

4. Market Size and Growth Projections

Multiple research firms have published market sizing for India's healthcare AI sector, with valuations ranging depending on scope definition. The consensus trajectory points to aggressive growth through the end of the decade.

Note on scope variance: Market size estimates vary significantly based on definition scope. IMARC's conservative estimate focuses narrowly on AI software and services for clinical use. Broader definitions encompassing digital health platforms, telemedicine AI, and health IT infrastructure yield higher figures. The directional consensus is clear: India's healthcare AI market is growing at approximately 30% CAGR.

Segment Breakdown (2025)

Based on IMARC Group's detailed segmentation:2

Growth Drivers

The market expansion from USD 119.4 million in 2020 to USD 435.7 million in 2025 was driven by three primary factors:

1. Rising diagnostic imaging volumes: India's growing middle class increasingly demands advanced diagnostics, creating massive datasets and workflow pressure that AI can address.
2. Hospital digitization: The ABDM push and competitive pressure are driving EMR adoption, creating the digital substrate that AI requires.
3. Cloud computing economics: Affordable cloud infrastructure (including subsidized GPU access through IndiaAI) has made AI deployment viable for institutions that cannot afford on-premise hardware.

Investment Highlights

Apollo Hospitals, India's largest hospital chain, announced plans to double its AI investments over the next two to three years, focusing on clinical documentation automation and diagnostic support.12

5. Adoption Barriers and Solutions

Despite strong top-line growth, clinical AI adoption in India faces five structural barriers that limit penetration beyond large hospital chains and urban centres.

Barrier 1: Digital Literacy and Workforce Readiness

The Elsevier study highlighted significant gaps in structured AI training for clinicians. Many doctors, particularly those trained before 2015, have limited exposure to digital tools beyond basic smartphone use. In rural areas, both practitioners and patients face digital literacy challenges that extend beyond AI to basic computer and internet familiarity.1

Emerging solutions: Voice-first interfaces that eliminate keyboard dependency; vernacular language support in clinical software; government-funded training programs through IndiaAI labs; peer learning networks through medical associations.

Barrier 2: Cost Constraints for Small Practices

India has an estimated 1.5 million medical practitioners operating in small settings. For a solo practitioner earning INR 3-8 lakh monthly, enterprise EMR systems costing INR 5-15 lakh for setup plus monthly fees represent a significant financial burden. Most cannot justify ROI for AI tools priced for hospital budgets.

Emerging solutions: SaaS-model pricing at INR 500-2,000 per month; freemium tiers for basic digitization; government incentives through DHIS; cloud-native platforms requiring zero hardware investment.

Barrier 3: Infrastructure and Connectivity

Reliable internet connectivity remains inconsistent in semi-urban and rural India. AI systems requiring real-time cloud processing face practical deployment challenges in areas with intermittent connectivity. Power reliability compounds the issue.

Emerging solutions: Offline-capable AI with sync-when-connected architectures; edge computing for latency-sensitive applications; India's expanding 5G infrastructure; government broadband programs under BharatNet.

Barrier 4: Interoperability and Data Fragmentation

Despite ABDM's progress, many existing clinic software systems use proprietary data formats that cannot communicate with each other. Patient data remains siloed across fragmented systems, limiting the comprehensiveness of AI-driven insights.6

Emerging solutions: ABDM's FHIR-based interoperability standards; Unified Health Interface mandating open protocols; market pressure from patients demanding portable records; API-first architectures in new platforms.

Barrier 5: Trust and Clinical Validation

Clinician trust in AI recommendations varies widely. Concerns about liability for AI-assisted decisions, the "black box" nature of deep learning models, and the relevance of models trained on non-Indian populations create adoption friction. Only 19% of healthcare institutions globally reported a high degree of success with deployed AI in 2025.13

Emerging solutions: Explainable AI with transparent reasoning chains; India-trained models using local patient data; published performance metrics and clinical accountability processes; regulatory frameworks requiring clinical validation on Indian populations.

6. Regulatory Framework

India's regulatory approach to healthcare AI is evolving rapidly, with three major frameworks converging to shape the landscape.

Digital Personal Data Protection Act, 2023 (DPDP Act)

The DPDP Act, together with the DPDP Rules published in 2025, establishes India's comprehensive data protection regime. For healthcare, this means:14

• Consent architecture: Health data collection requires explicit, informed consent through standalone notices written in plain language.
• Data localization: Certain categories of sensitive health data must be stored within India.
• Breach notification: Mandatory reporting of data breaches to authorities and affected individuals.
• Purpose limitation: Health data collected for treatment cannot be repurposed for commercial AI training without fresh consent.
• Patient rights: Right to access, correction, and erasure of personal health data.

The KPMG analysis notes that the DPDP framework creates particularly significant compliance requirements for small healthcare setups that previously operated with minimal data governance.14

Medical Device Rules, 2017 (MDR) and SaMD Regulation

AI used for diagnostic interpretation is classified as Software-as-a-Medical-Device (SaMD) and regulated by the Central Drugs Standard Control Organisation (CDSCO). The 2023 amendment introduced explicit SaMD provisions:9

• Most radiology AI products are classified as Class B or Class C devices
• Import or sale requires CDSCO registration via an Indian licence holder
• Manufacturers must maintain ISO 13485 quality management systems
• Clinical evidence requirements vary by risk class

India AI Governance Guidelines, 2026

Released at the AI Impact Summit in February 2026, the India AI Governance Guidelines represent the government's comprehensive framework for AI regulation across all sectors, including healthcare. The framework is anchored in seven guiding "Sutras" (principles) and adopts a principle-based, techno-legal approach.15

Key institutional recommendations include:

• AI Governance Group: A whole-of-government coordination body
• Technology and Policy Expert Committee: Technical advisory body for sector-specific guidance
• AI Safety Institute: Dedicated institution for evaluating AI safety and testing

The guidelines explicitly prioritize "innovation over restraint," positioning AI as a catalyst for inclusive growth while establishing guardrails. This philosophy aligns with India's broader "AI for All" strategy rather than the precautionary principle dominant in EU regulation.

Regulatory Comparison

7. Case Studies

Case Study A: AI-Powered Radiology at Scale

Context

A network of diagnostic centres operating across 15 Tier 2 and Tier 3 cities in South India faced a persistent radiologist shortage. Average turnaround time for CT and MRI reports exceeded 48 hours, with some complex cases taking up to 72 hours. Patient complaints about delayed reports were increasing, and referring physicians were diverting to competitors.

Implementation

The network adopted a cloud-native radiology AI platform that combined automated triage, AI-assisted pre-reads, and a pool of remote radiologists. The platform was deployed across all 15 centres in under 10 days, requiring no on-premise hardware installation.

Results

• Report turnaround time reduced from 48 hours to under 4 hours for routine scans
• Critical findings (bleeds, fractures, pneumothorax) flagged and reported within 30 minutes
• Radiologist productivity increased by approximately 35% through AI-assisted workflows
• Patient satisfaction scores improved measurably within the first quarter

Case Study B: EMR and Clinical Decision Support in Outpatient Practice

Context

A multi-specialty clinic group with 45 doctors across 8 locations in Western India was struggling with inconsistent documentation, missed follow-ups, and inability to track treatment outcomes across patient visits. Clinical protocols varied by physician with no standardization.

Implementation

The group deployed an AI-powered EMR system with voice-to-text documentation, automated clinical decision support alerts, and integrated patient communication. The AI layer analyzed symptoms against evidence-based protocols and flagged potential drug interactions and missed diagnostics.

Results

• Documentation time per consultation reduced from 8-10 minutes to 2-3 minutes
• Drug interaction alerts prevented an estimated 12 adverse events per month across the group
• Follow-up compliance improved by 28% through automated patient reminders
• The system identified patterns suggesting undiagnosed diabetes in 4% of adult patients who presented for other conditions

Case Study C: TB Screening in Public Health Programs

Context

India accounts for approximately 27% of the world's tuberculosis cases. National TB programs require mass screening, but trained radiologists are scarce in the districts with highest disease burden.

Implementation

AI-powered chest X-ray interpretation was deployed across public health screening programs in several high-burden states. Portable X-ray units paired with AI interpretation enabled screening at primary health centres and community camps without requiring on-site radiologists.

Results

• Screening throughput increased by over 300% compared to radiologist-only interpretation
• AI sensitivity for TB detection exceeded 95%, comparable to trained radiologists
• Time from X-ray capture to preliminary result reduced from days to under 60 seconds
• Early detection rates improved, enabling treatment initiation before advanced disease progression

8. Future Outlook 2026-2030

The period from 2026 to 2030 is likely to be defined by three structural shifts that will reshape how clinical AI operates in India.

Shift 1: From Pilot to Platform

The Indian market has matured past the "AI pilot" stage. The question is no longer whether AI works in clinical settings but how to deploy it at scale efficiently. The market is consolidating toward platform approaches: integrated systems that combine multiple AI capabilities (documentation, diagnostics, decision support, communication) into unified workflows, rather than standalone point solutions that each require separate integration.

By 2028, we expect the majority of new AI deployments in Indian clinics to be platform-based rather than single-function tools. This mirrors the broader enterprise software trajectory where integrated suites displaced best-of-breed point solutions.

Shift 2: Small Clinic Digitization Wave

The combination of government incentives (DHIS), infrastructure mandates (ABDM interoperability requirements), patient expectations (digital health records), and affordable SaaS solutions will drive a significant digitization wave among India's small clinics between 2026 and 2030.

This represents the largest addressable market segment by volume. An estimated 500,000+ clinics will adopt their first digital clinical platform during this period, creating enormous demand for simple, affordable, vernacular-language solutions that work on basic smartphones and intermittent connectivity.

Shift 3: India-Trained Foundation Models

Current clinical AI in India often relies on models trained primarily on Western patient populations. The combination of ABDM's growing health data corpus (100+ crore linked records), IndiaAI's compute infrastructure (38,000+ GPUs), and local AI talent is creating conditions for truly India-native clinical AI models. These models, trained on Indian patient demographics, disease prevalence patterns, and clinical workflows, will outperform imported solutions for the Indian context.

Timeline Projections

Risks to the Outlook

• Regulatory overreach: If the principle-based framework tips toward heavy compliance requirements, small startups may be priced out of the market.
• Data quality: ABDM's scale is impressive but data quality and completeness vary enormously across facilities. AI trained on inconsistent data produces inconsistent results.
• Talent drain: India produces excellent AI researchers but retaining them domestically against global compensation packages remains challenging.
• Trust erosion: A single high-profile AI diagnostic failure could set adoption back significantly in a market where physician authority remains culturally dominant.

9. Recommendations for Practitioners

For healthcare practitioners evaluating clinical AI adoption in 2026, the following recommendations synthesize the lessons from early adopters and market dynamics.

For Small and Mid-Size Clinics

1. Start with digitization, not AI. The first step is getting patient data into structured digital format. Choose an ABDM-compliant EMR system with a clear AI roadmap. AI is only as good as the data it operates on.
2. Choose platform over point solution. A single integrated system that handles documentation, scheduling, billing, and clinical support is more sustainable than assembling multiple tools. Look for platforms that grow with your practice.
3. Prioritize ease of use. The best AI is invisible AI. If a system requires more than 15 minutes of training per feature, adoption will fail. Voice-first interfaces and vernacular language support are not luxuries; they are requirements.
4. Leverage government incentives. Register on ABDM, claim DHIS incentives, and explore eSushrut@Clinic if you need a zero-cost starting point. The government is actively subsidizing digitization.
5. Plan for interoperability. Any system you adopt should support ABDM standards (FHIR-based health records, ABHA integration). Proprietary lock-in will become increasingly costly as patient expectations for portable records grow.

For Hospital Chains and Large Facilities

1. Move beyond radiology. If your AI journey started with imaging (the most common entry point), expand to clinical documentation, predictive analytics for patient flow, and automated quality monitoring.
2. Demand India-trained models. Ask AI vendors what fraction of their training data comes from Indian patient populations. Models trained exclusively on Western data underperform on Indian demographics, disease prevalence, and imaging protocols.
3. Integrate AI into workflows, not alongside them. AI tools that require clinicians to switch contexts or perform extra steps will be abandoned. Successful implementations embed AI within existing clinical workflows seamlessly.
4. Measure and publish outcomes. Track AI-influenced clinical metrics (turnaround times, diagnostic accuracy, follow-up rates) and contribute to India's evidence base for clinical AI effectiveness.
5. Prepare for regulatory requirements. The AI Governance Guidelines signal that sector-specific AI rules are coming. Proactive compliance and documentation of AI governance will be advantageous.

For Technology Providers and Startups

1. Build for the clinic, not the hospital. The underserved market is India's hundreds of thousands of small practices. Solutions must work on basic smartphones, tolerate intermittent connectivity, support vernacular languages, and cost under INR 2,000 per month.
2. ABDM integration is table stakes. Any health-tech product launched in 2026 without ABDM compliance is building on sand. The government's digital health infrastructure is not optional; it is the foundation.
3. Prioritize clinical validation on Indian populations. Publish performance data disaggregated by Indian demographics. This builds trust with clinicians and differentiates against imported solutions with unclear local applicability.
4. Design for the doctor's workflow, not the demo. The gap between impressive AI demonstrations and daily clinical utility remains wide. Solutions that save doctors time on their most burdensome tasks (documentation, follow-up tracking, insurance paperwork) will win over solutions that showcase impressive but peripheral capabilities.